Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Journal of the American Medical Informatics Association : JAMIA|April 27, 2012
Stochastic model search with binary outcomes for genome-wide association studiesAlberto Russu, Alberto Malovini, Annibale A Puca, et al.IEEE Transactions on Bio-Medical Engineering|August 18, 2011
Bayesian population modeling of phase I dose escalation studies: Gaussian process versus parametric approachesAlberto Russu, Italo Poggesi, Roberto Gomeni, et al.CPT: Pharmacometrics & Systems Pharmacology|November 21, 2024
Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertensionLene Nygaard Axelsen, Anne Kümmel, Juan Jose Perez Ruixo, et al.Computer Methods and Programs in Biomedicine|July 19, 2011
Bayesian population approaches to the analysis of dose escalation studiesAlberto Russu, Giuseppe De Nicolao, Italo Poggesi, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 19, 2013
A PCA approach to population analysis: with application to a Phase II depression trialEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2014
Continuous-time Markov modelling of flexible-dose depression trialsEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 23, 2011
Modelling of the outcome of non-inferiority trials by integration of historical dataAlberto Russu, Erik van Zwet, Giuseppe De Nicolao, et al.Mathematical Biosciences|December 8, 2014
Population modelling of patient responses in antidepressant studies: a stochastic approachEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 16, 2014
Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo responseEleonora Marostica, Alberto Russu, Shuying Yang, et al.Journal of Clinical Psychopharmacology|November 6, 2019
Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month FormulationsAlberto Russu, Adam Savitz, Maju Mathews, et al.Pageof 3